Sara Reardon

5.1k total citations
314 papers, 3.1k citations indexed

About

Sara Reardon is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Sara Reardon has authored 314 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Public Health, Environmental and Occupational Health, 62 papers in Reproductive Medicine and 58 papers in Molecular Biology. Recurrent topics in Sara Reardon's work include Science, Research, and Medicine (61 papers), Health and Medical Research Impacts (30 papers) and Biotechnology and Related Fields (26 papers). Sara Reardon is often cited by papers focused on Science, Research, and Medicine (61 papers), Health and Medical Research Impacts (30 papers) and Biotechnology and Related Fields (26 papers). Sara Reardon collaborates with scholars based in United States, Canada and Germany. Sara Reardon's co-authors include David Cyranoski, Thomas A. Reh, Michael Karl, Yumi Ueki, Byron H. Hartman, Sean Georgi, Branden R. Nelson, Deepak A. Lamba, Alexandra Witze and Jeff Tollefson and has published in prestigious journals such as Nature, Science and Nature Medicine.

In The Last Decade

Sara Reardon

288 papers receiving 2.9k citations

Peers

Sara Reardon
Rebecca Lee United States
Gretchen Vogel United States
Michael J. Miller United States
Hyejung Lee South Korea
James Thompson United States
Mark D. Allen United Kingdom
Elie Dolgin United States
Rebecca Lee United States
Sara Reardon
Citations per year, relative to Sara Reardon Sara Reardon (= 1×) peers Rebecca Lee

Countries citing papers authored by Sara Reardon

Since Specialization
Citations

This map shows the geographic impact of Sara Reardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Reardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Reardon more than expected).

Fields of papers citing papers by Sara Reardon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Reardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Reardon. The network helps show where Sara Reardon may publish in the future.

Co-authorship network of co-authors of Sara Reardon

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Reardon. A scholar is included among the top collaborators of Sara Reardon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Reardon. Sara Reardon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reardon, Sara. (2025). NIH kills existing grants on transgender issues. Science. 387(6739). 1136–1136. 1 indexed citations
2.
Reardon, Sara. (2024). Mpox is spreading rapidly. Here are the questions researchers are racing to answer. Nature. 633(8028). 16–17. 8 indexed citations
3.
Reardon, Sara. (2024). Ancient DNA reveals origins of multiple sclerosis in Europe. Nature. 625(7995). 431–432.
4.
Reardon, Sara. (2023). US could soon approve MDMA therapy — opening an era of psychedelic medicine. Nature. 616(7957). 428–430. 6 indexed citations
5.
Reardon, Sara. (2023). How psychedelic drugs achieve their potent health benefits. Nature. 618(7966). 654–655.
6.
Reardon, Sara. (2023). Antibiotic use in farming set to soar despite drug-resistance fears. Nature. 614(7948). 397–397. 27 indexed citations
7.
Reardon, Sara. (2023). The brain cells linked to protection against dementia. Nature. 622(7982). 229–230. 1 indexed citations
8.
Reardon, Sara. (2022). What does the future look like for monkeypox?. Nature. 610(7931). 250–252. 10 indexed citations
9.
Andrade, Mônica de, et al.. (2021). A Comparative Analysis of Reactive Müller Glia Gene Expression After Light Damage and microRNA-Depleted Müller Glia—Focus on microRNAs. Frontiers in Cell and Developmental Biology. 8. 620459–620459. 20 indexed citations
10.
Reardon, Sara, et al.. (2019). Hunting for New Drugs with AI The pharmaceutical industry is in a drug-discovery slump. How much can AI help?. Nature. 576(7787). 1 indexed citations
11.
Reardon, Sara. (2016). Welcome to the Cyborg Olympics. Nature. 536(7614). 20–22. 2 indexed citations
12.
Cyranoski, David & Sara Reardon. (2015). nature news ヒト胚ゲノム編集の波紋. Nature. 12(7). 10–12. 1 indexed citations
13.
Reardon, Sara. (2015). US government gives research chimps endangered-species protection. Nature. 2 indexed citations
14.
Vargas, Jesse D., et al.. (2014). DEAF1 Binds Unmethylated and Variably Spaced CpG Dinucleotide Motifs. PLoS ONE. 9(12). e115908–e115908. 9 indexed citations
15.
Reardon, Sara. (2014). Faulty forensic science under fire. Nature. 506(7486). 13–14. 6 indexed citations
16.
Reardon, Sara. (2013). China in the Arctic: less fish, more oil?. The New Scientist. 14. 1 indexed citations
17.
Reardon, Sara. (2013). DIY diagnostics for world's poorest. The New Scientist. 20–21. 1 indexed citations
18.
Ueki, Yumi, Michael Karl, Julia Pollak, et al.. (2012). P53 is required for the developmental restriction in Müller glial proliferation in mouse retina. Glia. 60(10). 1579–1589. 45 indexed citations
19.
Reardon, Sara. (2011). Playing by Ear. Science. 333(6051). 1816–1818. 13 indexed citations
20.
Nelson, Branden R., Yumi Ueki, Sara Reardon, et al.. (2011). Genome-Wide Analysis of Müller Glial Differentiation Reveals a Requirement for Notch Signaling in Postmitotic Cells to Maintain the Glial Fate. PLoS ONE. 6(8). e22817–e22817. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026